Overview
Clinical Benefits
- Increases cellular NAD+
- Reactivates dormant adipocyte lipolysis
- Visceral / total-fat reduction
- Improves metabolic rate
Administration
Subcutaneous injection (primary route). Oral capsule is an alternative delivery for users who cannot inject.
Drug class: nnmt inhibitor
Clinical Dosing
Typical dosage
50mg/day SubQ (or split 2 × 25mg AM/PM)
Starting dose
50mg
Cadence
Once daily (or AM + PM split)
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 50mg once daily SubQ (1.0 mL from 50 mg / 1 mL vial), OR split 2 × 0.5 mL AM + PM |
| Weeks 3-12 | 50mg daily SubQ, maintain single-dose or AM/PM split |
| Weeks 13+ | Cycle off 4 weeks |
Safety Profile
Side effects
- • Mild GI upset (oral)
- • Injection-site tenderness (SubQ)
- • Limited human trial data
Contraindications
- • Pregnancy
- • Liver disease
Frequently asked questions
5-Amino-1MQ is most commonly researched for: Increases cellular NAD+, Reactivates dormant adipocyte lipolysis, Visceral / total-fat reduction, Improves metabolic rate.
Ready to build a protocol with 5-Amino-1MQ?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.